AB176. Impact of squamous and/or glandular differentiation on recurrence and progression after transurethral resection for non-muscle invasive urothelial carcinoma of bladder Objective: To investigate the impact of squamous and/ or glandular differentiation on recurrence and progression in patients with non-muscle-invasive urothelial carcinoma of bladder (NMIUCB) following transurethral resection (TURBT). Methods: A total of 869 patients with NMIUCB treated with TURBT at our institution from January 2006 to January 2011 were selected retrospectively for the analysis. Correlations among squamous and/or glandular differentiation with other clinical and pathological features were assessed by chi-square. Recurrence-free survival (RFS) and progression-free survival (PFS) curves were estimated using the Kaplan-Meier method. Univariate and multivariate analyses were performed through a Cox proportional hazards regression model. Results: Among 869 consecutive patients, 232 (26.7%) patients had squamous and/or glandular differentiation. High grade tumors were more common in patients with squamous and/or glandular differentiation than those with pure UCB (P<0.001). Correlations between age (P=0.115), gender (P=0.184), tumor size (P=0.223), tumor multiplicity (P=0.108), pathological tumor stage (P=0.909) and squamous and/or glandular differentiation were not statistically significant. There was a statistically prominent tendency towards higher recurrence rate and shorter RFS time in patients with squamous and/or glandular differentiation. However, no statistically significant differences were observed in progression rate and PFS between the two groups. On multivariate Cox regression analysis, squamous and/or glandular differentiation was identified as an independent prognostic predictor of recurrence (HR 1.46, 95% CI, 1.10-1.92, P=0.008).
Conclusions:
The presence of squamous and/or glandular differentiation could be associated with higher recurrence rate and shorter RFS time in patients with NMUCB. It is an independent prognostic predictor of recurrence. Objective: Prostate cancer is the second common malignancies of men around the world. According to the database about prostate cancer of our institute, in our study, we will analyses prostate cancer patients with Gleason score 10 and investigate its clinical and pathological features. Methods: We retrospectively review 30 prostate cancer patients with complete clinical information in our hospital between July 2010 and July 2013. Results: The pathology of tissue specimens is that all of them are Gleason score 10. ECT shows that 10 with bone metastasis, 1 with lung metastasis. Mean value of total serum PSA is 56.35 ng/mL and average PSAD is 0.57. Mean BMI is 23.90, but there are 14 patients with a BMI more than 25 accounting for 47% of the total. Conclusions: By our initial research, we find that prostate cancer with Gleason 10 is the highest grade pathological malignancy tumor. It is usually found in elder men, especially more than 70 years old. Patients always have higher BMI and bigger total PSA and PSAD. Patients frequently have metastatic sites with seminal vesicles, bone and other places, however, it does not has a higher risk of metastasis. Therefore, we can see prostate cancers with Gleason 10 as special style to treat. 
